United States · FDA National Drug Code directory
Ribotin-E
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59088-182_f204c835-2fb6-27b1-e053-2995a90a43b9
- Product NDC
- 59088-182
- Form
- TABLET
- Composition / generic term
- Ferrous Fumarate, Folic Acid
- Labeler
- PureTek Corporation
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20210211
- Source listing expiry
- 20261231
Source-listed ingredients
- VITAMIN A ACETATE — 1500 ug/1
- ASCORBIC ACID — 250 mg/1
- CHOLECALCIFEROL — 13.75 ug/1
- .ALPHA.-TOCOPHEROL ACETATE, DL- — 45 mg/1
- THIAMINE MONONITRATE — 3.25 mg/1
- RIBOFLAVIN — 3.35 mg/1
- NIACINAMIDE — 22.5 mg/1
- PYRIDOXINE HYDROCHLORIDE — 6 mg/1
- FOLIC ACID — 500 ug/1
- CYANOCOBALAMIN — 13 ug/1
- BIOTIN — 100 ug/1
- PANTOTHENIC ACID — 15 mg/1
- CALCIUM CARBONATE — 75 mg/1
- FERROUS FUMARATE — 9 mg/1
- POTASSIUM IODIDE — 25 ug/1
- MAGNESIUM OXIDE — 37.5 mg/1
- ZINC OXIDE — 15 mg/1
- SELENIUM — 30 ug/1
- CUPROUS OXIDE — 1 mg/1
- MANGANESE SULFATE — .75 mg/1
- CHROMIUM NICOTINATE — 37.5 ug/1
- MOLYBDENUM — 25 ug/1
- POTASSIUM CHLORIDE — 24.5 mg/1
- BORON — 25 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE, PLASTIC (59088-182-58) · 59088-182-58
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →